![TLR7 Ligand Augments GM-CSF-Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells]()
TLR7 Ligand Augments GM-CSF-Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic CellsNarusawa, M.; Inoue, H.; Sakamoto, C.; Matsumura, Y.; Takahashi, A.; Inoue, T.; Watanabe, A.; Miyamoto, S.; Miura, Y.; Hijikata, Y.; Tanaka, Y.; Inoue, M.; Takayama, K.; Okazaki, T.; Hasegawa, M.; Nakanishi, Y.; Tani, K. · Cancer Immunology Research · 2014